Oncologic Drugs Advisory Committee

September 10-11, 2001

68th Meeting

Consultants (voting)

For IntraDose:

Marion Everett Couch, M.D., Ph.D.

Assistant Professor

Department of Otolaryngology, Head and Neck Surgery

Johns Hopkins Medical Center, JHOC

601 N. Caroline Street, Suite 6252

Baltimore, MD 21287

 

Bonnie Glisson, M.D.

Section Chief, Head and Neck Medical Oncology

Department of Thoracic and Head and Neck Medical Oncology

University of Texas M. D. Anderson Cancer Center

1515 Holcombe Boulevard, Box 80

Houston, Texas 77030-4009

 

Lawrence V. Rubinstein, Ph.D.

Head, Developmental Clinical Trials and Preclinical Studies Section

Biometric Research Branch

National Cancer Institute

6130 Executive Blvd EPN, Room 8130

Rockville, MD 20852

 

For Zevalin®, (Consultants Center for Biologics Evaluation and Research)

James D. Bridges, M.D.

Maryland Regional Cancer Care LLC

40 West Gude Drive

Rockville, MD 20850

 

Alexandra M. Levine, M.D.

Professor of Medicine

University of Southern California/Norris Cancer Center

Division of Hematology, MS 34

1441 Eastlake Avenue

Los Angeles, CA 90033

 

For Gliadel:

Jan Craig Buckner, M.D.

Mayo Medical School

Division of Medical Oncology

200 First Street, SW

Rochester, Minnesota 55905

Howard A. Fine, MD

National Cancer Institute

National Institute of Neurological Disorder and Stroke

Building 10/Room 12S245-MSC1911

10 Center Drive

Bethesda, Maryland 20892

 

Lemuel A. Moye, M.D., Ph.D.

University of Texas Health Sciences Center

Houston School of Public Health

Coordinating Center for Clinical Trials

1200 Herman Pressler St. Suite 801

Houston, Texas 77030

 

Lawrence V. Rubinstein, Ph.D.

Head, Developmental Clinical Trials and Preclinical Studies Section

Biometric Research Branch

National Cancer Institute

6130 Executive Blvd EPN, Room 8130

Rockville, MD 20852

 

Patient Representatives (voting)

For Clinical Trial Designs for First-Line Treatment of Metastatic Breast Cancer

Musa Mayer - New York, New York

For IntraDose: Glenn Gruett - Appleton, Wisconsin

For Zevalin: Susan Krivacic Austin, Texas

For Gliadel: Craig Lustig - Washington, D.C.

 

 

Oncologic Drugs Advisory Committee

66th Meeting

 

Industry Representative (non-voting)

George H. Ohye

3 Heritage Hills Court

Skillman, New Jersey 08558-2340

 

 

Guests and Guest Speakers (non-voting)

For Clinical Trial Designs for First-Line Treatment of Metastatic Breast Cancer

Nancy Davidson, M.D.
Professor of Oncology - Experimental Therapeutics
School of Medicine
Johns Hopkins University (JHU)
East Baltimore Medical Center
1650 Orleans St.
Baltimore, Maryland

I. Craig Henderson, M.D.

School of Medicine

University of California at San Francisco

Breast Cancer Program

Box 1710

San Francisco, California 94143

 

For Zevalin®:

Ruby F. Meredith, M.D., Ph.D.

Professor, Radiation Oncology

Radiation Oncology Department

University of Alabama Birmingham Medical School

619 South 19th Street

Birmingham, Alabama 35233-6832